TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access Strategy
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Artificial Intelligence and Data Science
            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications (CTA)
            • Global Procedure Management
            • Health Authority / Agency Interaction

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
            • Risk Management Support

          • Quality

            • Commercialization Readiness
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
            • Validation
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Toxicology Services

          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management

          • Quality

            • Commissioning and Qualification
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Systems
            • Validation
            • Vendor Audit
            • Vendor Management and Oversight

          • Medical Affairs

            • Medical Information
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medical Device Services
            • Medicinal Products
            • Pharmaceutical
            • Veterinary Drugs

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacoepidemiology
            • Statistical Services
            • Supporting Rx to OTC switches
            • Technology Enabled Services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events > News

News

CO.DON AG achieves remarkable outcome, receiving EU marketing authorization for Spherox

CO.DON AG achieves remarkable outcome, receiving EU marketing authorization for Spherox

14th July 2017

PharmaLex Group strengthens biosimilar expertise

PharmaLex Group strengthens biosimilar expertise

10th July 2017

PharmaLex Group expands service provision with the addition of health economics in the Nordics

PharmaLex Group expands service provision with the addition of health economics in the Nordics

4th July 2017

EMA and CMDh issue Q&As relating to Brexit

EMA and CMDh issue Q&As relating to Brexit

5th June 2017

The Licensing of Medicines – Consequences of UK “Brexit Vote”

The Licensing of Medicines – Consequences of UK “Brexit Vote”

31st May 2017

CMDh update guidance on RMS switch following Brexit

CMDh update guidance on RMS switch following Brexit

22nd May 2017

PharmaLex Group further strengthens quality management and compliance services

PharmaLex Group further strengthens quality management and compliance services

15th May 2017

Regulatory preparedness – implications of the UK leaving the EU

Regulatory preparedness – implications of the UK leaving the EU

12th May 2017

PharmaLex Group gains momentum in the US with acquisition of The Degge Group, Ltd.

PharmaLex Group gains momentum in the US with acquisition of The Degge Group, Ltd.

2nd May 2017

PharmaLex Group builds US presence with acquisition of Safis Solutions

PharmaLex Group builds US presence with acquisition of Safis Solutions

24th April 2017

PharmaLex Group accelerates growth by strengthening office in Bulgaria

PharmaLex Group accelerates growth by strengthening office in Bulgaria

21st March 2017

PharmaLex Group adds Pharmacovigilance to its service portfolio in the US

PharmaLex Group adds Pharmacovigilance to its service portfolio in the US

31st January 2017
1
23456789101112131415
…1617181920
prevnext
Upcoming Webinars

September 29th, 2020

QbD and process Characterization

October 8th, 2020

Marketing a drug in France, what are the responsibilities of an exploitant?

December 8th, 2020

Applied AI for Pharmaceutical R&D

Upcoming Events

September 24 - 25th, 2020

Biotech Atelier

September 21 - 29th, 2020

Society of Quality Assurance (SQA) Virtual Meeting and Quality College 2020

October 5 - 7th, 2020

TOPRA Symposium 2020

Visit us at booth #37

Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC
PharmaLex
©2020 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.